BLIS Technologies Ltd

BLT

Company Profile

  • Business description

    BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.

  • Contact

    399 Moray Place
    Dunedin Central
    DunedinOTA9016
    NZL

    T: +64 34740988

    https://www.blis.co.nz

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 March 2026

    Employees

    34

Stocks News & Analysis

stocks

3 Warren Buffett stocks to avoid today

These are the most overvalued stocks in Berkshire Hathaway’s portfolio.
stocks

Should you invest in small caps?

With small capitalisation stocks gaining momentum, there are important considerations to determine whether they are right for your portfolio. 
stocks

Strong second half anticipated for ASX mining play

A more focused business model should benefit the company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,066.204.700.05%
CAC 407,795.4232.03-0.41%
DAX 4023,534.83131.98-0.56%
Dow JONES (US)45,947.32173.96-0.38%
FTSE 1009,213.9836.45-0.39%
HKSE26,302.75181.93-0.69%
NASDAQ22,384.70113.16-0.50%
Nikkei 22545,629.79125.14-0.27%
NZX 50 Index13,075.3178.48-0.60%
S&P 5006,604.7233.25-0.50%
S&P/ASX 2008,779.505.000.06%
SSE Composite Index3,848.324.98-0.13%

Market Movers